nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA13—telencephalic ventricle—malignant glioma	0.0205	0.059	CbGeAlD
Zonisamide—CA8—blood vessel—malignant glioma	0.0119	0.0341	CbGeAlD
Zonisamide—Pneumonia aspiration—Carmustine—malignant glioma	0.0119	0.0354	CcSEcCtD
Zonisamide—Status epilepticus—Temozolomide—malignant glioma	0.0106	0.0317	CcSEcCtD
Zonisamide—Tonic-clonic seizures—Carmustine—malignant glioma	0.00962	0.0287	CcSEcCtD
Zonisamide—Facial paralysis—Carmustine—malignant glioma	0.00815	0.0243	CcSEcCtD
Zonisamide—SCN2B—telencephalon—malignant glioma	0.00678	0.0195	CbGeAlD
Zonisamide—CA10—brainstem—malignant glioma	0.00662	0.019	CbGeAlD
Zonisamide—CA8—brainstem—malignant glioma	0.00649	0.0186	CbGeAlD
Zonisamide—VIIth nerve paralysis—Carmustine—malignant glioma	0.00632	0.0188	CcSEcCtD
Zonisamide—SCN1B—telencephalon—malignant glioma	0.00613	0.0176	CbGeAlD
Zonisamide—CA10—telencephalon—malignant glioma	0.00588	0.0169	CbGeAlD
Zonisamide—SCN3B—telencephalon—malignant glioma	0.00566	0.0162	CbGeAlD
Zonisamide—CA13—brainstem—malignant glioma	0.00556	0.016	CbGeAlD
Zonisamide—Grand mal convulsion—Carmustine—malignant glioma	0.00544	0.0162	CcSEcCtD
Zonisamide—SCN2B—medulla oblongata—malignant glioma	0.00532	0.0153	CbGeAlD
Zonisamide—Faecal incontinence—Carmustine—malignant glioma	0.00514	0.0153	CcSEcCtD
Zonisamide—Faecal incontinence—Temozolomide—malignant glioma	0.00496	0.0148	CcSEcCtD
Zonisamide—CA13—telencephalon—malignant glioma	0.00493	0.0142	CbGeAlD
Zonisamide—SCN2B—midbrain—malignant glioma	0.00487	0.014	CbGeAlD
Zonisamide—SCN2B—spinal cord—malignant glioma	0.00475	0.0136	CbGeAlD
Zonisamide—CACNA1I—telencephalon—malignant glioma	0.0047	0.0135	CbGeAlD
Zonisamide—CA11—brainstem—malignant glioma	0.00466	0.0134	CbGeAlD
Zonisamide—CA10—medulla oblongata—malignant glioma	0.00462	0.0133	CbGeAlD
Zonisamide—CA11—retina—malignant glioma	0.0045	0.0129	CbGeAlD
Zonisamide—SCN3B—medulla oblongata—malignant glioma	0.00444	0.0128	CbGeAlD
Zonisamide—CA10—midbrain—malignant glioma	0.00422	0.0121	CbGeAlD
Zonisamide—CA11—telencephalon—malignant glioma	0.00414	0.0119	CbGeAlD
Zonisamide—Myasthenia—Carmustine—malignant glioma	0.00412	0.0123	CcSEcCtD
Zonisamide—CA10—spinal cord—malignant glioma	0.00412	0.0118	CbGeAlD
Zonisamide—SCN3B—midbrain—malignant glioma	0.00406	0.0117	CbGeAlD
Zonisamide—Encephalopathy—Carmustine—malignant glioma	0.00404	0.012	CcSEcCtD
Zonisamide—SCN3B—spinal cord—malignant glioma	0.00396	0.0114	CbGeAlD
Zonisamide—Parosmia—Temozolomide—malignant glioma	0.00386	0.0115	CcSEcCtD
Zonisamide—SCN2B—central nervous system—malignant glioma	0.00385	0.0111	CbGeAlD
Zonisamide—Hypokinesia—Carmustine—malignant glioma	0.00384	0.0114	CcSEcCtD
Zonisamide—SCN4B—medulla oblongata—malignant glioma	0.00378	0.0108	CbGeAlD
Zonisamide—SCN2B—cerebellum—malignant glioma	0.00376	0.0108	CbGeAlD
Zonisamide—SCN1B—central nervous system—malignant glioma	0.00348	0.01	CbGeAlD
Zonisamide—SCN4B—midbrain—malignant glioma	0.00345	0.00992	CbGeAlD
Zonisamide—Scotoma—Carmustine—malignant glioma	0.00341	0.0102	CcSEcCtD
Zonisamide—SCN1B—cerebellum—malignant glioma	0.0034	0.00978	CbGeAlD
Zonisamide—Menorrhagia—Temozolomide—malignant glioma	0.00338	0.0101	CcSEcCtD
Zonisamide—SCN4B—spinal cord—malignant glioma	0.00337	0.00967	CbGeAlD
Zonisamide—CA10—central nervous system—malignant glioma	0.00334	0.00959	CbGeAlD
Zonisamide—Scotoma—Temozolomide—malignant glioma	0.0033	0.00983	CcSEcCtD
Zonisamide—CA8—central nervous system—malignant glioma	0.00327	0.0094	CbGeAlD
Zonisamide—CA10—cerebellum—malignant glioma	0.00326	0.00937	CbGeAlD
Zonisamide—CA11—medulla oblongata—malignant glioma	0.00325	0.00934	CbGeAlD
Zonisamide—CACNA1G—telencephalon—malignant glioma	0.00322	0.00924	CbGeAlD
Zonisamide—SCN3B—central nervous system—malignant glioma	0.00321	0.00923	CbGeAlD
Zonisamide—CA8—cerebellum—malignant glioma	0.0032	0.00919	CbGeAlD
Zonisamide—Hyperaesthesia—Temozolomide—malignant glioma	0.00319	0.00951	CcSEcCtD
Zonisamide—Memory impairment—Temozolomide—malignant glioma	0.00319	0.00951	CcSEcCtD
Zonisamide—SCN3B—cerebellum—malignant glioma	0.00314	0.00902	CbGeAlD
Zonisamide—SCN2B—brain—malignant glioma	0.00306	0.00878	CbGeAlD
Zonisamide—Petechiae—Temozolomide—malignant glioma	0.00304	0.00908	CcSEcCtD
Zonisamide—Speech disorder—Carmustine—malignant glioma	0.00301	0.00898	CcSEcCtD
Zonisamide—Liver injury—Temozolomide—malignant glioma	0.00298	0.00887	CcSEcCtD
Zonisamide—CA11—midbrain—malignant glioma	0.00297	0.00854	CbGeAlD
Zonisamide—Accidental injury—Carmustine—malignant glioma	0.00293	0.00873	CcSEcCtD
Zonisamide—Speech disorder—Temozolomide—malignant glioma	0.00291	0.00868	CcSEcCtD
Zonisamide—CA11—spinal cord—malignant glioma	0.0029	0.00833	CbGeAlD
Zonisamide—Disturbance in attention—Temozolomide—malignant glioma	0.00289	0.00862	CcSEcCtD
Zonisamide—Amenorrhoea—Temozolomide—malignant glioma	0.00285	0.0085	CcSEcCtD
Zonisamide—CA13—central nervous system—malignant glioma	0.0028	0.00805	CbGeAlD
Zonisamide—SCN1B—brain—malignant glioma	0.00277	0.00794	CbGeAlD
Zonisamide—Leukocytosis—Carmustine—malignant glioma	0.00276	0.00822	CcSEcCtD
Zonisamide—CA13—cerebellum—malignant glioma	0.00274	0.00787	CbGeAlD
Zonisamide—SCN4B—central nervous system—malignant glioma	0.00273	0.00785	CbGeAlD
Zonisamide—SCN4B—cerebellum—malignant glioma	0.00267	0.00767	CbGeAlD
Zonisamide—Gait disturbance—Carmustine—malignant glioma	0.00266	0.00792	CcSEcCtD
Zonisamide—CA10—brain—malignant glioma	0.00265	0.00761	CbGeAlD
Zonisamide—Coordination abnormal—Carmustine—malignant glioma	0.00264	0.00787	CcSEcCtD
Zonisamide—CACNA1I—cerebellum—malignant glioma	0.00261	0.00749	CbGeAlD
Zonisamide—CA8—brain—malignant glioma	0.0026	0.00747	CbGeAlD
Zonisamide—Pulmonary embolism—Carmustine—malignant glioma	0.00259	0.00773	CcSEcCtD
Zonisamide—Gait disturbance—Temozolomide—malignant glioma	0.00257	0.00765	CcSEcCtD
Zonisamide—SCN3B—brain—malignant glioma	0.00255	0.00733	CbGeAlD
Zonisamide—Coordination abnormal—Temozolomide—malignant glioma	0.00255	0.0076	CcSEcCtD
Zonisamide—CA3—telencephalon—malignant glioma	0.00253	0.00725	CbGeAlD
Zonisamide—Pulmonary embolism—Temozolomide—malignant glioma	0.0025	0.00747	CcSEcCtD
Zonisamide—Depressed level of consciousness—Carmustine—malignant glioma	0.0025	0.00746	CcSEcCtD
Zonisamide—Urinary incontinence—Carmustine—malignant glioma	0.0025	0.00746	CcSEcCtD
Zonisamide—Neuropathy—Carmustine—malignant glioma	0.00243	0.00725	CcSEcCtD
Zonisamide—Influenza like illness—Temozolomide—malignant glioma	0.00243	0.00725	CcSEcCtD
Zonisamide—Depressed level of consciousness—Temozolomide—malignant glioma	0.00242	0.00721	CcSEcCtD
Zonisamide—Urinary incontinence—Temozolomide—malignant glioma	0.00242	0.00721	CcSEcCtD
Zonisamide—Coma—Carmustine—malignant glioma	0.00237	0.00706	CcSEcCtD
Zonisamide—SCN11A—spinal cord—malignant glioma	0.00236	0.00679	CbGeAlD
Zonisamide—CA11—central nervous system—malignant glioma	0.00235	0.00676	CbGeAlD
Zonisamide—Neuropathy—Temozolomide—malignant glioma	0.00235	0.00701	CcSEcCtD
Zonisamide—Aplastic anaemia—Temozolomide—malignant glioma	0.00235	0.00701	CcSEcCtD
Zonisamide—Gynaecomastia—Carmustine—malignant glioma	0.00232	0.00691	CcSEcCtD
Zonisamide—CA11—cerebellum—malignant glioma	0.0023	0.0066	CbGeAlD
Zonisamide—CA14—telencephalon—malignant glioma	0.00229	0.00659	CbGeAlD
Zonisamide—CA13—brain—malignant glioma	0.00222	0.00639	CbGeAlD
Zonisamide—SCN1A—brainstem—malignant glioma	0.00218	0.00626	CbGeAlD
Zonisamide—Thrombophlebitis—Carmustine—malignant glioma	0.00217	0.00648	CcSEcCtD
Zonisamide—SCN4B—brain—malignant glioma	0.00217	0.00623	CbGeAlD
Zonisamide—CACNA1I—brain—malignant glioma	0.00212	0.00609	CbGeAlD
Zonisamide—Thrombophlebitis—Temozolomide—malignant glioma	0.0021	0.00626	CcSEcCtD
Zonisamide—Gastroenteritis—Temozolomide—malignant glioma	0.00205	0.00611	CcSEcCtD
Zonisamide—Injury—Carmustine—malignant glioma	0.00205	0.0061	CcSEcCtD
Zonisamide—Deafness—Temozolomide—malignant glioma	0.00203	0.00606	CcSEcCtD
Zonisamide—Amnesia—Carmustine—malignant glioma	0.002	0.00597	CcSEcCtD
Zonisamide—SCN2A—brainstem—malignant glioma	0.002	0.00574	CbGeAlD
Zonisamide—CA7—midbrain—malignant glioma	0.00198	0.00568	CbGeAlD
Zonisamide—Amnesia—Temozolomide—malignant glioma	0.00194	0.00577	CcSEcCtD
Zonisamide—SCN1A—telencephalon—malignant glioma	0.00193	0.00555	CbGeAlD
Zonisamide—SCN11A—central nervous system—malignant glioma	0.00192	0.00551	CbGeAlD
Zonisamide—Thirst—Temozolomide—malignant glioma	0.00191	0.00569	CcSEcCtD
Zonisamide—Hyponatraemia—Carmustine—malignant glioma	0.00189	0.00563	CcSEcCtD
Zonisamide—Diplopia—Carmustine—malignant glioma	0.00188	0.00561	CcSEcCtD
Zonisamide—CA11—brain—malignant glioma	0.00187	0.00536	CbGeAlD
Zonisamide—CACNA1G—central nervous system—malignant glioma	0.00183	0.00525	CbGeAlD
Zonisamide—Diplopia—Temozolomide—malignant glioma	0.00182	0.00542	CcSEcCtD
Zonisamide—Face oedema—Carmustine—malignant glioma	0.00182	0.00541	CcSEcCtD
Zonisamide—CA14—medulla oblongata—malignant glioma	0.0018	0.00518	CbGeAlD
Zonisamide—Affect lability—Temozolomide—malignant glioma	0.00179	0.00533	CcSEcCtD
Zonisamide—CA12—telencephalon—malignant glioma	0.00179	0.00514	CbGeAlD
Zonisamide—CACNA1G—cerebellum—malignant glioma	0.00179	0.00514	CbGeAlD
Zonisamide—SCN2A—telencephalon—malignant glioma	0.00177	0.0051	CbGeAlD
Zonisamide—Ataxia—Carmustine—malignant glioma	0.00177	0.00527	CcSEcCtD
Zonisamide—Face oedema—Temozolomide—malignant glioma	0.00176	0.00523	CcSEcCtD
Zonisamide—Liver function test abnormal—Carmustine—malignant glioma	0.00174	0.00518	CcSEcCtD
Zonisamide—Mood swings—Temozolomide—malignant glioma	0.00172	0.00513	CcSEcCtD
Zonisamide—Hypokalaemia—Carmustine—malignant glioma	0.00171	0.0051	CcSEcCtD
Zonisamide—Ataxia—Temozolomide—malignant glioma	0.00171	0.0051	CcSEcCtD
Zonisamide—Dehydration—Temozolomide—malignant glioma	0.00169	0.00504	CcSEcCtD
Zonisamide—Dry skin—Temozolomide—malignant glioma	0.00167	0.00497	CcSEcCtD
Zonisamide—Muscular weakness—Carmustine—malignant glioma	0.00166	0.00495	CcSEcCtD
Zonisamide—Hypokalaemia—Temozolomide—malignant glioma	0.00165	0.00493	CcSEcCtD
Zonisamide—CA14—midbrain—malignant glioma	0.00165	0.00473	CbGeAlD
Zonisamide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00164	0.00488	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00164	0.00488	CcSEcCtD
Zonisamide—Dysphagia—Carmustine—malignant glioma	0.00163	0.00485	CcSEcCtD
Zonisamide—SCN9A—midbrain—malignant glioma	0.00161	0.00463	CbGeAlD
Zonisamide—CA14—spinal cord—malignant glioma	0.00161	0.00461	CbGeAlD
Zonisamide—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.0016	0.00478	CcSEcCtD
Zonisamide—Muscular weakness—Temozolomide—malignant glioma	0.0016	0.00478	CcSEcCtD
Zonisamide—SCN9A—spinal cord—malignant glioma	0.00157	0.00452	CbGeAlD
Zonisamide—Dysphagia—Temozolomide—malignant glioma	0.00157	0.00468	CcSEcCtD
Zonisamide—SCN3A—telencephalon—malignant glioma	0.00156	0.00448	CbGeAlD
Zonisamide—Pancytopenia—Carmustine—malignant glioma	0.00154	0.0046	CcSEcCtD
Zonisamide—CA7—cerebellum—malignant glioma	0.00153	0.00439	CbGeAlD
Zonisamide—SCN11A—brain—malignant glioma	0.00152	0.00437	CbGeAlD
Zonisamide—SCN1A—medulla oblongata—malignant glioma	0.00152	0.00436	CbGeAlD
Zonisamide—Pancytopenia—Temozolomide—malignant glioma	0.00149	0.00445	CcSEcCtD
Zonisamide—Dysuria—Temozolomide—malignant glioma	0.00147	0.00438	CcSEcCtD
Zonisamide—Pneumonia—Carmustine—malignant glioma	0.00146	0.00435	CcSEcCtD
Zonisamide—CACNA1G—brain—malignant glioma	0.00145	0.00417	CbGeAlD
Zonisamide—Pollakiuria—Temozolomide—malignant glioma	0.00145	0.00433	CcSEcCtD
Zonisamide—Erectile dysfunction—Temozolomide—malignant glioma	0.00145	0.00431	CcSEcCtD
Zonisamide—Depression—Carmustine—malignant glioma	0.00145	0.00431	CcSEcCtD
Zonisamide—CA3—central nervous system—malignant glioma	0.00144	0.00412	CbGeAlD
Zonisamide—Weight increased—Temozolomide—malignant glioma	0.00143	0.00426	CcSEcCtD
Zonisamide—Renal failure—Carmustine—malignant glioma	0.00143	0.00425	CcSEcCtD
Zonisamide—Weight decreased—Temozolomide—malignant glioma	0.00142	0.00424	CcSEcCtD
Zonisamide—Neuropathy peripheral—Carmustine—malignant glioma	0.00142	0.00424	CcSEcCtD
Zonisamide—CA1—telencephalon—malignant glioma	0.00142	0.00407	CbGeAlD
Zonisamide—MAOB—embryo—malignant glioma	0.00141	0.00406	CbGeAlD
Zonisamide—Stomatitis—Carmustine—malignant glioma	0.00141	0.00421	CcSEcCtD
Zonisamide—Urinary tract infection—Carmustine—malignant glioma	0.00141	0.0042	CcSEcCtD
Zonisamide—Pneumonia—Temozolomide—malignant glioma	0.00141	0.0042	CcSEcCtD
Zonisamide—Depression—Temozolomide—malignant glioma	0.0014	0.00416	CcSEcCtD
Zonisamide—SCN2A—medulla oblongata—malignant glioma	0.00139	0.004	CbGeAlD
Zonisamide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00139	0.00414	CcSEcCtD
Zonisamide—SCN1A—midbrain—malignant glioma	0.00139	0.00399	CbGeAlD
Zonisamide—Neuropathy peripheral—Temozolomide—malignant glioma	0.00137	0.00409	CcSEcCtD
Zonisamide—Stomatitis—Temozolomide—malignant glioma	0.00137	0.00407	CcSEcCtD
Zonisamide—Urinary tract infection—Temozolomide—malignant glioma	0.00136	0.00406	CcSEcCtD
Zonisamide—SCN1A—spinal cord—malignant glioma	0.00135	0.00389	CbGeAlD
Zonisamide—CA9—cerebellum—malignant glioma	0.00134	0.00386	CbGeAlD
Zonisamide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00133	0.00395	CcSEcCtD
Zonisamide—MAOB—brainstem—malignant glioma	0.0013	0.00372	CbGeAlD
Zonisamide—Hallucination—Carmustine—malignant glioma	0.0013	0.00386	CcSEcCtD
Zonisamide—Oedema peripheral—Carmustine—malignant glioma	0.00128	0.00382	CcSEcCtD
Zonisamide—Connective tissue disorder—Carmustine—malignant glioma	0.00128	0.00381	CcSEcCtD
Zonisamide—CA14—cerebellum—malignant glioma	0.00127	0.00366	CbGeAlD
Zonisamide—SCN2A—midbrain—malignant glioma	0.00127	0.00366	CbGeAlD
Zonisamide—Hallucination—Temozolomide—malignant glioma	0.00125	0.00373	CcSEcCtD
Zonisamide—Pharyngitis—Temozolomide—malignant glioma	0.00125	0.00372	CcSEcCtD
Zonisamide—CA4—brainstem—malignant glioma	0.00125	0.00358	CbGeAlD
Zonisamide—SCN2A—spinal cord—malignant glioma	0.00124	0.00357	CbGeAlD
Zonisamide—CA7—brain—malignant glioma	0.00124	0.00357	CbGeAlD
Zonisamide—Urinary tract disorder—Temozolomide—malignant glioma	0.00124	0.0037	CcSEcCtD
Zonisamide—Oedema peripheral—Temozolomide—malignant glioma	0.00124	0.00369	CcSEcCtD
Zonisamide—Connective tissue disorder—Temozolomide—malignant glioma	0.00124	0.00368	CcSEcCtD
Zonisamide—Urethral disorder—Temozolomide—malignant glioma	0.00123	0.00368	CcSEcCtD
Zonisamide—SCN3A—medulla oblongata—malignant glioma	0.00123	0.00352	CbGeAlD
Zonisamide—Eye disorder—Carmustine—malignant glioma	0.00122	0.00363	CcSEcCtD
Zonisamide—MAOA—embryo—malignant glioma	0.00121	0.00346	CbGeAlD
Zonisamide—Erythema multiforme—Temozolomide—malignant glioma	0.00119	0.00355	CcSEcCtD
Zonisamide—Eye disorder—Temozolomide—malignant glioma	0.00118	0.0035	CcSEcCtD
Zonisamide—Tinnitus—Temozolomide—malignant glioma	0.00117	0.0035	CcSEcCtD
Zonisamide—CACNA1H—cerebellum—malignant glioma	0.00117	0.00336	CbGeAlD
Zonisamide—Alopecia—Carmustine—malignant glioma	0.00115	0.00343	CcSEcCtD
Zonisamide—MAOB—telencephalon—malignant glioma	0.00115	0.0033	CbGeAlD
Zonisamide—Mental disorder—Carmustine—malignant glioma	0.00114	0.0034	CcSEcCtD
Zonisamide—CA3—brain—malignant glioma	0.00114	0.00327	CbGeAlD
Zonisamide—SCN4A—central nervous system—malignant glioma	0.00114	0.00327	CbGeAlD
Zonisamide—Immune system disorder—Temozolomide—malignant glioma	0.00114	0.00339	CcSEcCtD
Zonisamide—Mediastinal disorder—Temozolomide—malignant glioma	0.00113	0.00338	CcSEcCtD
Zonisamide—Malnutrition—Carmustine—malignant glioma	0.00113	0.00338	CcSEcCtD
Zonisamide—CA2—embryo—malignant glioma	0.00113	0.00324	CbGeAlD
Zonisamide—SCN3A—midbrain—malignant glioma	0.00112	0.00322	CbGeAlD
Zonisamide—Alopecia—Temozolomide—malignant glioma	0.00111	0.00331	CcSEcCtD
Zonisamide—CA4—telencephalon—malignant glioma	0.00111	0.00318	CbGeAlD
Zonisamide—MAOA—brainstem—malignant glioma	0.00111	0.00317	CbGeAlD
Zonisamide—Mental disorder—Temozolomide—malignant glioma	0.0011	0.00328	CcSEcCtD
Zonisamide—SCN1A—central nervous system—malignant glioma	0.0011	0.00316	CbGeAlD
Zonisamide—Malnutrition—Temozolomide—malignant glioma	0.0011	0.00326	CcSEcCtD
Zonisamide—SCN3A—spinal cord—malignant glioma	0.00109	0.00314	CbGeAlD
Zonisamide—SCN1A—cerebellum—malignant glioma	0.00107	0.00308	CbGeAlD
Zonisamide—Dysgeusia—Temozolomide—malignant glioma	0.00107	0.0032	CcSEcCtD
Zonisamide—MAOA—retina—malignant glioma	0.00107	0.00306	CbGeAlD
Zonisamide—Tremor—Carmustine—malignant glioma	0.00106	0.00316	CcSEcCtD
Zonisamide—Anaemia—Carmustine—malignant glioma	0.00105	0.00312	CcSEcCtD
Zonisamide—Agitation—Carmustine—malignant glioma	0.00104	0.0031	CcSEcCtD
Zonisamide—CA14—brain—malignant glioma	0.00104	0.00297	CbGeAlD
Zonisamide—CA2—brainstem—malignant glioma	0.00103	0.00297	CbGeAlD
Zonisamide—Tremor—Temozolomide—malignant glioma	0.00103	0.00306	CcSEcCtD
Zonisamide—CA12—central nervous system—malignant glioma	0.00102	0.00292	CbGeAlD
Zonisamide—Ill-defined disorder—Temozolomide—malignant glioma	0.00102	0.00303	CcSEcCtD
Zonisamide—Leukopenia—Carmustine—malignant glioma	0.00101	0.00302	CcSEcCtD
Zonisamide—SCN9A—brain—malignant glioma	0.00101	0.00291	CbGeAlD
Zonisamide—Anaemia—Temozolomide—malignant glioma	0.00101	0.00302	CcSEcCtD
Zonisamide—SCN2A—central nervous system—malignant glioma	0.00101	0.0029	CbGeAlD
Zonisamide—Agitation—Temozolomide—malignant glioma	0.00101	0.003	CcSEcCtD
Zonisamide—CA2—retina—malignant glioma	0.000998	0.00287	CbGeAlD
Zonisamide—CA1—spinal cord—malignant glioma	0.000993	0.00285	CbGeAlD
Zonisamide—Malaise—Temozolomide—malignant glioma	0.000987	0.00294	CcSEcCtD
Zonisamide—SCN2A—cerebellum—malignant glioma	0.000986	0.00283	CbGeAlD
Zonisamide—Vertigo—Temozolomide—malignant glioma	0.000984	0.00293	CcSEcCtD
Zonisamide—Convulsion—Carmustine—malignant glioma	0.000982	0.00293	CcSEcCtD
Zonisamide—MAOA—telencephalon—malignant glioma	0.000981	0.00282	CbGeAlD
Zonisamide—Leukopenia—Temozolomide—malignant glioma	0.00098	0.00292	CcSEcCtD
Zonisamide—Hypertension—Carmustine—malignant glioma	0.000978	0.00292	CcSEcCtD
Zonisamide—Palpitations—Temozolomide—malignant glioma	0.000968	0.00288	CcSEcCtD
Zonisamide—Chest pain—Carmustine—malignant glioma	0.000965	0.00288	CcSEcCtD
Zonisamide—Myalgia—Carmustine—malignant glioma	0.000965	0.00288	CcSEcCtD
Zonisamide—Anxiety—Carmustine—malignant glioma	0.000961	0.00287	CcSEcCtD
Zonisamide—Cough—Temozolomide—malignant glioma	0.000956	0.00285	CcSEcCtD
Zonisamide—CACNA1H—brain—malignant glioma	0.00095	0.00273	CbGeAlD
Zonisamide—Convulsion—Temozolomide—malignant glioma	0.000949	0.00283	CcSEcCtD
Zonisamide—Hypertension—Temozolomide—malignant glioma	0.000945	0.00282	CcSEcCtD
Zonisamide—Confusional state—Carmustine—malignant glioma	0.000932	0.00278	CcSEcCtD
Zonisamide—Myalgia—Temozolomide—malignant glioma	0.000932	0.00278	CcSEcCtD
Zonisamide—Arthralgia—Temozolomide—malignant glioma	0.000932	0.00278	CcSEcCtD
Zonisamide—Anxiety—Temozolomide—malignant glioma	0.000929	0.00277	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000926	0.00276	CcSEcCtD
Zonisamide—Oedema—Carmustine—malignant glioma	0.000925	0.00276	CcSEcCtD
Zonisamide—Discomfort—Temozolomide—malignant glioma	0.000921	0.00275	CcSEcCtD
Zonisamide—Infection—Carmustine—malignant glioma	0.000919	0.00274	CcSEcCtD
Zonisamide—CA2—telencephalon—malignant glioma	0.000918	0.00264	CbGeAlD
Zonisamide—CA5B—central nervous system—malignant glioma	0.000912	0.00262	CbGeAlD
Zonisamide—Dry mouth—Temozolomide—malignant glioma	0.000912	0.00272	CcSEcCtD
Zonisamide—Thrombocytopenia—Carmustine—malignant glioma	0.000905	0.0027	CcSEcCtD
Zonisamide—SCN4A—brain—malignant glioma	0.000905	0.0026	CbGeAlD
Zonisamide—MAOB—medulla oblongata—malignant glioma	0.000904	0.00259	CbGeAlD
Zonisamide—Tachycardia—Carmustine—malignant glioma	0.000903	0.00269	CcSEcCtD
Zonisamide—Confusional state—Temozolomide—malignant glioma	0.000901	0.00269	CcSEcCtD
Zonisamide—Oedema—Temozolomide—malignant glioma	0.000894	0.00266	CcSEcCtD
Zonisamide—Infection—Temozolomide—malignant glioma	0.000888	0.00265	CcSEcCtD
Zonisamide—SCN3A—central nervous system—malignant glioma	0.000886	0.00255	CbGeAlD
Zonisamide—SCN5A—central nervous system—malignant glioma	0.000884	0.00254	CbGeAlD
Zonisamide—Anorexia—Carmustine—malignant glioma	0.000882	0.00263	CcSEcCtD
Zonisamide—Nervous system disorder—Temozolomide—malignant glioma	0.000876	0.00261	CcSEcCtD
Zonisamide—Thrombocytopenia—Temozolomide—malignant glioma	0.000875	0.00261	CcSEcCtD
Zonisamide—SCN1A—brain—malignant glioma	0.000872	0.00251	CbGeAlD
Zonisamide—CA4—medulla oblongata—malignant glioma	0.00087	0.0025	CbGeAlD
Zonisamide—Skin disorder—Temozolomide—malignant glioma	0.000868	0.00259	CcSEcCtD
Zonisamide—SCN3A—cerebellum—malignant glioma	0.000866	0.00249	CbGeAlD
Zonisamide—Hypotension—Carmustine—malignant glioma	0.000864	0.00258	CcSEcCtD
Zonisamide—Hyperhidrosis—Temozolomide—malignant glioma	0.000864	0.00258	CcSEcCtD
Zonisamide—Anorexia—Temozolomide—malignant glioma	0.000852	0.00254	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000843	0.00251	CcSEcCtD
Zonisamide—Insomnia—Carmustine—malignant glioma	0.000836	0.00249	CcSEcCtD
Zonisamide—Paraesthesia—Carmustine—malignant glioma	0.00083	0.00248	CcSEcCtD
Zonisamide—AOX1—cerebellum—malignant glioma	0.000829	0.00238	CbGeAlD
Zonisamide—MAOB—midbrain—malignant glioma	0.000826	0.00237	CbGeAlD
Zonisamide—Dyspnoea—Carmustine—malignant glioma	0.000824	0.00246	CcSEcCtD
Zonisamide—Somnolence—Carmustine—malignant glioma	0.000822	0.00245	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000814	0.00243	CcSEcCtD
Zonisamide—Insomnia—Temozolomide—malignant glioma	0.000808	0.00241	CcSEcCtD
Zonisamide—CA12—brain—malignant glioma	0.000807	0.00232	CbGeAlD
Zonisamide—MAOB—spinal cord—malignant glioma	0.000806	0.00231	CbGeAlD
Zonisamide—CA1—central nervous system—malignant glioma	0.000805	0.00231	CbGeAlD
Zonisamide—Decreased appetite—Carmustine—malignant glioma	0.000804	0.0024	CcSEcCtD
Zonisamide—Paraesthesia—Temozolomide—malignant glioma	0.000802	0.00239	CcSEcCtD
Zonisamide—SCN2A—brain—malignant glioma	0.000801	0.0023	CbGeAlD
Zonisamide—Gastrointestinal disorder—Carmustine—malignant glioma	0.000798	0.00238	CcSEcCtD
Zonisamide—Dyspnoea—Temozolomide—malignant glioma	0.000797	0.00237	CcSEcCtD
Zonisamide—CA4—midbrain—malignant glioma	0.000795	0.00228	CbGeAlD
Zonisamide—Somnolence—Temozolomide—malignant glioma	0.000794	0.00237	CcSEcCtD
Zonisamide—Constipation—Carmustine—malignant glioma	0.000791	0.00236	CcSEcCtD
Zonisamide—Dyspepsia—Temozolomide—malignant glioma	0.000787	0.00234	CcSEcCtD
Zonisamide—Decreased appetite—Temozolomide—malignant glioma	0.000777	0.00232	CcSEcCtD
Zonisamide—CA4—spinal cord—malignant glioma	0.000776	0.00223	CbGeAlD
Zonisamide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000772	0.0023	CcSEcCtD
Zonisamide—MAOA—medulla oblongata—malignant glioma	0.000771	0.00221	CbGeAlD
Zonisamide—Fatigue—Temozolomide—malignant glioma	0.00077	0.0023	CcSEcCtD
Zonisamide—Constipation—Temozolomide—malignant glioma	0.000764	0.00228	CcSEcCtD
Zonisamide—Feeling abnormal—Carmustine—malignant glioma	0.000762	0.00227	CcSEcCtD
Zonisamide—Gastrointestinal pain—Carmustine—malignant glioma	0.000756	0.00225	CcSEcCtD
Zonisamide—Feeling abnormal—Temozolomide—malignant glioma	0.000736	0.0022	CcSEcCtD
Zonisamide—Abdominal pain—Carmustine—malignant glioma	0.000731	0.00218	CcSEcCtD
Zonisamide—Body temperature increased—Carmustine—malignant glioma	0.000731	0.00218	CcSEcCtD
Zonisamide—Gastrointestinal pain—Temozolomide—malignant glioma	0.000731	0.00218	CcSEcCtD
Zonisamide—CA5B—brain—malignant glioma	0.000724	0.00208	CbGeAlD
Zonisamide—CA2—medulla oblongata—malignant glioma	0.000722	0.00207	CbGeAlD
Zonisamide—Urticaria—Temozolomide—malignant glioma	0.00071	0.00212	CcSEcCtD
Zonisamide—Abdominal pain—Temozolomide—malignant glioma	0.000706	0.00211	CcSEcCtD
Zonisamide—Body temperature increased—Temozolomide—malignant glioma	0.000706	0.00211	CcSEcCtD
Zonisamide—MAOA—midbrain—malignant glioma	0.000705	0.00202	CbGeAlD
Zonisamide—SCN3A—brain—malignant glioma	0.000704	0.00202	CbGeAlD
Zonisamide—SCN5A—brain—malignant glioma	0.000702	0.00201	CbGeAlD
Zonisamide—MAOA—spinal cord—malignant glioma	0.000687	0.00197	CbGeAlD
Zonisamide—Hypersensitivity—Carmustine—malignant glioma	0.000681	0.00203	CcSEcCtD
Zonisamide—AOX1—brain—malignant glioma	0.000673	0.00193	CbGeAlD
Zonisamide—Asthenia—Carmustine—malignant glioma	0.000664	0.00198	CcSEcCtD
Zonisamide—CA2—midbrain—malignant glioma	0.00066	0.00189	CbGeAlD
Zonisamide—Hypersensitivity—Temozolomide—malignant glioma	0.000658	0.00196	CcSEcCtD
Zonisamide—MAOB—central nervous system—malignant glioma	0.000654	0.00188	CbGeAlD
Zonisamide—CA2—spinal cord—malignant glioma	0.000644	0.00185	CbGeAlD
Zonisamide—Asthenia—Temozolomide—malignant glioma	0.000641	0.00191	CcSEcCtD
Zonisamide—CA1—brain—malignant glioma	0.000639	0.00184	CbGeAlD
Zonisamide—MAOB—cerebellum—malignant glioma	0.000639	0.00183	CbGeAlD
Zonisamide—Diarrhoea—Carmustine—malignant glioma	0.000633	0.00189	CcSEcCtD
Zonisamide—Pruritus—Temozolomide—malignant glioma	0.000632	0.00188	CcSEcCtD
Zonisamide—CA4—central nervous system—malignant glioma	0.00063	0.00181	CbGeAlD
Zonisamide—CA4—cerebellum—malignant glioma	0.000615	0.00177	CbGeAlD
Zonisamide—Dizziness—Carmustine—malignant glioma	0.000612	0.00182	CcSEcCtD
Zonisamide—Diarrhoea—Temozolomide—malignant glioma	0.000611	0.00182	CcSEcCtD
Zonisamide—Dizziness—Temozolomide—malignant glioma	0.000591	0.00176	CcSEcCtD
Zonisamide—Vomiting—Carmustine—malignant glioma	0.000588	0.00175	CcSEcCtD
Zonisamide—Rash—Carmustine—malignant glioma	0.000583	0.00174	CcSEcCtD
Zonisamide—Dermatitis—Carmustine—malignant glioma	0.000583	0.00174	CcSEcCtD
Zonisamide—Headache—Carmustine—malignant glioma	0.000579	0.00173	CcSEcCtD
Zonisamide—Vomiting—Temozolomide—malignant glioma	0.000568	0.00169	CcSEcCtD
Zonisamide—Rash—Temozolomide—malignant glioma	0.000563	0.00168	CcSEcCtD
Zonisamide—Dermatitis—Temozolomide—malignant glioma	0.000563	0.00168	CcSEcCtD
Zonisamide—Headache—Temozolomide—malignant glioma	0.00056	0.00167	CcSEcCtD
Zonisamide—MAOA—central nervous system—malignant glioma	0.000558	0.0016	CbGeAlD
Zonisamide—Nausea—Carmustine—malignant glioma	0.000549	0.00164	CcSEcCtD
Zonisamide—MAOA—cerebellum—malignant glioma	0.000545	0.00157	CbGeAlD
Zonisamide—Nausea—Temozolomide—malignant glioma	0.000531	0.00158	CcSEcCtD
Zonisamide—CA2—central nervous system—malignant glioma	0.000522	0.0015	CbGeAlD
Zonisamide—MAOB—brain—malignant glioma	0.000519	0.00149	CbGeAlD
Zonisamide—CA2—cerebellum—malignant glioma	0.00051	0.00147	CbGeAlD
Zonisamide—CA4—brain—malignant glioma	0.0005	0.00144	CbGeAlD
Zonisamide—MAOA—brain—malignant glioma	0.000443	0.00127	CbGeAlD
Zonisamide—CA2—brain—malignant glioma	0.000414	0.00119	CbGeAlD
Zonisamide—CYP3A4—central nervous system—malignant glioma	0.000337	0.000967	CbGeAlD
Zonisamide—CA5B—Metabolism—PIK3CG—malignant glioma	5.1e-05	0.000161	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CG—malignant glioma	5.1e-05	0.000161	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTP1—malignant glioma	5.08e-05	0.000161	CbGpPWpGaD
Zonisamide—CA4—Metabolism—NCOR1—malignant glioma	5.08e-05	0.000161	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—malignant glioma	5.03e-05	0.000159	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—malignant glioma	5.03e-05	0.000159	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—malignant glioma	4.98e-05	0.000158	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTP1—malignant glioma	4.98e-05	0.000158	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RAF1—malignant glioma	4.97e-05	0.000157	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—IDH1—malignant glioma	4.97e-05	0.000157	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—malignant glioma	4.94e-05	0.000156	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CAT—malignant glioma	4.94e-05	0.000156	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CD—malignant glioma	4.93e-05	0.000156	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PPARG—malignant glioma	4.93e-05	0.000156	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PPARG—malignant glioma	4.93e-05	0.000156	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—malignant glioma	4.92e-05	0.000156	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NCOR1—malignant glioma	4.87e-05	0.000154	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—malignant glioma	4.85e-05	0.000153	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CAT—malignant glioma	4.85e-05	0.000153	CbGpPWpGaD
Zonisamide—AOX1—Disease—TERT—malignant glioma	4.82e-05	0.000152	CbGpPWpGaD
Zonisamide—AOX1—Disease—HLA-A—malignant glioma	4.82e-05	0.000152	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SPHK1—malignant glioma	4.81e-05	0.000152	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CD—malignant glioma	4.81e-05	0.000152	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CD—malignant glioma	4.81e-05	0.000152	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—malignant glioma	4.79e-05	0.000151	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—malignant glioma	4.79e-05	0.000151	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—malignant glioma	4.78e-05	0.000151	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—malignant glioma	4.75e-05	0.00015	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—malignant glioma	4.75e-05	0.00015	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CG—malignant glioma	4.73e-05	0.00015	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP2C18—malignant glioma	4.71e-05	0.000149	CbGpPWpGaD
Zonisamide—AOX1—Disease—PDGFB—malignant glioma	4.7e-05	0.000149	CbGpPWpGaD
Zonisamide—AOX1—Disease—FGFR1—malignant glioma	4.68e-05	0.000148	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NCOR1—malignant glioma	4.67e-05	0.000148	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—malignant glioma	4.62e-05	0.000146	CbGpPWpGaD
Zonisamide—AOX1—Disease—HIF1A—malignant glioma	4.61e-05	0.000146	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—malignant glioma	4.58e-05	0.000145	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NCOR1—malignant glioma	4.58e-05	0.000145	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PPARG—malignant glioma	4.56e-05	0.000144	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—malignant glioma	4.51e-05	0.000143	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CD—malignant glioma	4.49e-05	0.000142	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CD—malignant glioma	4.49e-05	0.000142	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTP1—malignant glioma	4.47e-05	0.000141	CbGpPWpGaD
Zonisamide—AOX1—Disease—CAV1—malignant glioma	4.46e-05	0.000141	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RTEL1—malignant glioma	4.44e-05	0.000141	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.4e-05	0.000139	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CAT—malignant glioma	4.34e-05	0.000137	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.33e-05	0.000137	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CB—malignant glioma	4.3e-05	0.000136	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—malignant glioma	4.26e-05	0.000135	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—COX8A—malignant glioma	4.24e-05	0.000134	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—malignant glioma	4.22e-05	0.000133	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTP1—malignant glioma	4.21e-05	0.000133	CbGpPWpGaD
Zonisamide—AOX1—Disease—BAD—malignant glioma	4.19e-05	0.000133	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CB—malignant glioma	4.19e-05	0.000132	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CB—malignant glioma	4.19e-05	0.000132	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CD—malignant glioma	4.16e-05	0.000131	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—malignant glioma	4.15e-05	0.000131	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—malignant glioma	4.15e-05	0.000131	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOTCH1—malignant glioma	4.15e-05	0.000131	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CAV1—malignant glioma	4.14e-05	0.000131	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NCOR1—malignant glioma	4.1e-05	0.00013	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CAT—malignant glioma	4.1e-05	0.000129	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—AKT1—malignant glioma	4.08e-05	0.000129	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3CA—malignant glioma	4.07e-05	0.000129	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD80—malignant glioma	4.07e-05	0.000129	CbGpPWpGaD
Zonisamide—AOX1—Disease—APC—malignant glioma	4.06e-05	0.000128	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGF—malignant glioma	4.01e-05	0.000127	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTPN11—malignant glioma	3.99e-05	0.000126	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CAV1—malignant glioma	3.97e-05	0.000125	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—AKT1—malignant glioma	3.95e-05	0.000125	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CB—malignant glioma	3.91e-05	0.000124	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CB—malignant glioma	3.91e-05	0.000124	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—AKT1—malignant glioma	3.88e-05	0.000123	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—malignant glioma	3.87e-05	0.000123	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—malignant glioma	3.87e-05	0.000123	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NCOR1—malignant glioma	3.87e-05	0.000122	CbGpPWpGaD
Zonisamide—AOX1—Disease—BRAF—malignant glioma	3.81e-05	0.000121	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTT1—malignant glioma	3.81e-05	0.00012	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CAV1—malignant glioma	3.8e-05	0.00012	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.79e-05	0.00012	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—malignant glioma	3.79e-05	0.00012	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CG—malignant glioma	3.77e-05	0.000119	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—STAT3—malignant glioma	3.75e-05	0.000119	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CAV1—malignant glioma	3.73e-05	0.000118	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTEN—malignant glioma	3.71e-05	0.000117	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT2—malignant glioma	3.71e-05	0.000117	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—AKT1—malignant glioma	3.71e-05	0.000117	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PPARG—malignant glioma	3.64e-05	0.000115	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CB—malignant glioma	3.62e-05	0.000115	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTEN—malignant glioma	3.62e-05	0.000114	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTEN—malignant glioma	3.62e-05	0.000114	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CG—malignant glioma	3.61e-05	0.000114	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ASMT—malignant glioma	3.61e-05	0.000114	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—malignant glioma	3.59e-05	0.000114	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS1—malignant glioma	3.57e-05	0.000113	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CD—malignant glioma	3.57e-05	0.000113	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—AKT1—malignant glioma	3.57e-05	0.000113	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—AKT1—malignant glioma	3.57e-05	0.000113	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.53e-05	0.000112	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PPARG—malignant glioma	3.49e-05	0.00011	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CG—malignant glioma	3.47e-05	0.00011	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—AKT1—malignant glioma	3.44e-05	0.000109	CbGpPWpGaD
Zonisamide—AOX1—Disease—FGF2—malignant glioma	3.42e-05	0.000108	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—malignant glioma	3.41e-05	0.000108	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CG—malignant glioma	3.4e-05	0.000107	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BCAN—malignant glioma	3.39e-05	0.000107	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—malignant glioma	3.38e-05	0.000107	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—malignant glioma	3.38e-05	0.000107	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CAV1—malignant glioma	3.34e-05	0.000106	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PPARG—malignant glioma	3.34e-05	0.000106	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—malignant glioma	3.32e-05	0.000105	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—BCHE—malignant glioma	3.32e-05	0.000105	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CD—malignant glioma	3.31e-05	0.000105	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PPARG—malignant glioma	3.28e-05	0.000104	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC5A5—malignant glioma	3.28e-05	0.000104	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—malignant glioma	3.25e-05	0.000103	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—malignant glioma	3.22e-05	0.000102	CbGpPWpGaD
Zonisamide—AOX1—Disease—MDM2—malignant glioma	3.2e-05	0.000101	CbGpPWpGaD
Zonisamide—AOX1—Disease—RAF1—malignant glioma	3.19e-05	0.000101	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CD—malignant glioma	3.18e-05	0.0001	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CAV1—malignant glioma	3.15e-05	9.97e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—malignant glioma	3.15e-05	9.96e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—malignant glioma	3.13e-05	9.9e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CB—malignant glioma	3.11e-05	9.83e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—malignant glioma	3.08e-05	9.74e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CG—malignant glioma	3.05e-05	9.63e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CD—malignant glioma	3.05e-05	9.63e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CD—malignant glioma	2.99e-05	9.45e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PPARG—malignant glioma	2.94e-05	9.3e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CB—malignant glioma	2.89e-05	9.14e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CG—malignant glioma	2.87e-05	9.08e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—malignant glioma	2.86e-05	9.05e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PPARG—malignant glioma	2.77e-05	8.76e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CB—malignant glioma	2.77e-05	8.76e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—malignant glioma	2.74e-05	8.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—IDH2—malignant glioma	2.74e-05	8.65e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—malignant glioma	2.69e-05	8.5e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CD—malignant glioma	2.68e-05	8.47e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CB—malignant glioma	2.66e-05	8.4e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—malignant glioma	2.64e-05	8.35e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—malignant glioma	2.63e-05	8.32e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—malignant glioma	2.62e-05	8.29e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CB—malignant glioma	2.6e-05	8.24e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—malignant glioma	2.58e-05	8.16e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.58e-05	8.16e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.57e-05	8.13e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAT—malignant glioma	2.57e-05	8.13e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—malignant glioma	2.55e-05	8.07e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—malignant glioma	2.55e-05	8.07e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—COX8A—malignant glioma	2.55e-05	8.07e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CD—malignant glioma	2.52e-05	7.98e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—malignant glioma	2.5e-05	7.89e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NCOR1—malignant glioma	2.43e-05	7.67e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—malignant glioma	2.42e-05	7.64e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—malignant glioma	2.4e-05	7.6e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—malignant glioma	2.39e-05	7.57e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—malignant glioma	2.38e-05	7.54e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—malignant glioma	2.38e-05	7.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—IDH1—malignant glioma	2.35e-05	7.44e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CB—malignant glioma	2.33e-05	7.38e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—malignant glioma	2.31e-05	7.31e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—malignant glioma	2.29e-05	7.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SPHK1—malignant glioma	2.28e-05	7.2e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—malignant glioma	2.25e-05	7.12e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—malignant glioma	2.23e-05	7.06e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.23e-05	7.05e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—malignant glioma	2.21e-05	6.98e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CB—malignant glioma	2.2e-05	6.96e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—malignant glioma	2.18e-05	6.91e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—malignant glioma	2.18e-05	6.89e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ASMT—malignant glioma	2.17e-05	6.86e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—malignant glioma	2.14e-05	6.77e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.1e-05	6.65e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—malignant glioma	2.09e-05	6.6e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—malignant glioma	2.09e-05	6.6e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—malignant glioma	2.06e-05	6.52e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BCAN—malignant glioma	2.04e-05	6.45e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—malignant glioma	2.02e-05	6.38e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAV1—malignant glioma	1.98e-05	6.26e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—malignant glioma	1.95e-05	6.16e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—malignant glioma	1.95e-05	6.16e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.92e-05	6.06e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—malignant glioma	1.9e-05	6.01e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—malignant glioma	1.9e-05	5.99e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.85e-05	5.85e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—malignant glioma	1.8e-05	5.71e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—malignant glioma	1.8e-05	5.7e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CG—malignant glioma	1.8e-05	5.7e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—malignant glioma	1.76e-05	5.57e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARG—malignant glioma	1.74e-05	5.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS1—malignant glioma	1.69e-05	5.34e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—malignant glioma	1.69e-05	5.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.68e-05	5.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—IDH2—malignant glioma	1.64e-05	5.2e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—malignant glioma	1.62e-05	5.12e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—malignant glioma	1.59e-05	5.02e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CD—malignant glioma	1.58e-05	5.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BCHE—malignant glioma	1.57e-05	4.97e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.55e-05	4.91e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—malignant glioma	1.55e-05	4.9e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.55e-05	4.89e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.47e-05	4.64e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.45e-05	4.6e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—malignant glioma	1.44e-05	4.55e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—malignant glioma	1.42e-05	4.5e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—IDH1—malignant glioma	1.41e-05	4.47e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CB—malignant glioma	1.38e-05	4.37e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—malignant glioma	1.38e-05	4.36e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SPHK1—malignant glioma	1.37e-05	4.33e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—malignant glioma	1.37e-05	4.33e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—malignant glioma	1.34e-05	4.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.34e-05	4.24e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—malignant glioma	1.32e-05	4.18e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—malignant glioma	1.3e-05	4.1e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.27e-05	4.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—malignant glioma	1.25e-05	3.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAT—malignant glioma	1.22e-05	3.85e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—malignant glioma	1.19e-05	3.77e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—malignant glioma	1.16e-05	3.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOR1—malignant glioma	1.15e-05	3.63e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—malignant glioma	1.1e-05	3.47e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—malignant glioma	1.08e-05	3.43e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS1—malignant glioma	1.02e-05	3.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BCHE—malignant glioma	9.45e-06	2.99e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAV1—malignant glioma	9.36e-06	2.96e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.33e-06	2.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.95e-06	2.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CG—malignant glioma	8.53e-06	2.7e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—malignant glioma	8.42e-06	2.66e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARG—malignant glioma	8.23e-06	2.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—malignant glioma	7.52e-06	2.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CD—malignant glioma	7.5e-06	2.37e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAT—malignant glioma	7.31e-06	2.31e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOR1—malignant glioma	6.91e-06	2.18e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—malignant glioma	6.88e-06	2.17e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CB—malignant glioma	6.54e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—malignant glioma	6.48e-06	2.05e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—malignant glioma	5.65e-06	1.79e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAV1—malignant glioma	5.63e-06	1.78e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.13e-06	1.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARG—malignant glioma	4.95e-06	1.57e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.51e-06	1.43e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.98e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.93e-06	1.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—malignant glioma	3.89e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—malignant glioma	3.4e-06	1.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—malignant glioma	3.25e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.4e-06	7.58e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—malignant glioma	1.96e-06	6.19e-06	CbGpPWpGaD
